Xencor, Inc. (XNCR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Xencor, Inc. (XNCR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Xencor, Inc. (XNCR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Xencor, Inc. (XNCR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
40 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Xencor, Inc. (Xencor) is a biotechnology company that develops antibody and protein therapeutics for the treatment of cancer and autoimmune inflammation. The companys products include XmAb14045, XmAb 5871, XmAb 7195 and XmAb13676. Its XmAb5871 is a monoclonal antibody, which targets CD19 with its variable domain and uses the XmAb immune inhibitory Fc domain to target Fc?RIIb. The companys technologies include bispecific Fc domains, cytotoxic Fc domains, immune inhibitor Fc domains, and xtend Fc domains. It conducts clinical trials for new medicines. Xencor is headquartered in Monrovia, California, the US

Xencor, Inc. (XNCR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a sum

  
Source:
Document ID
GDPH138584D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Xencor, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Xencor, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Xencor, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Xencor, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Xencor, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Xencor, Inc., Pharmaceuticals &Healthcare, Deal Details1027
  Venture Financing101
    Xencor Raises US$7.6 Million In Venture Financing101
    Xencor Secures US$7.5 Million In Venture Financing111
  Partnerships121
    Amgen Terminates Co-Development Agreement with Xencor for XmAb5871122
    Xencor Enters Into Co-Development Agreement With Boehringer Ingelheim For Biosuperior Monoclonal Antibodies141
  Licensing Agreements151
    Novartis Enters into Licensing Agreement with Xencor152
    Xencor Enters into Licensing Agreement with Receptor Logic171
    Amgen Enters into Licensing Agreement with Xencor182
    Xencor Enters into Licensing Agreement with Novo Nordisk202
    Xencor Enters Into Licensing Agreement With Merck221
    Xencor Enters Into Licensing Agreement With CSL For Xtend Technology232
    Xencor Enters into Licensing Agreement with Alexion Pharma252
    sAber Bioscience Enters Into Licensing Agreement With Xencor For XmAb Technology271
    FPRT Bio Enters into Licensing Agreement with Xencor for XPro1595281
    MorphoSys Enters Into Licensing Agreement With Xencor292
  Equity Offering311
    Xencor Plans to Raise up to USD40 Million in Public Offering of Shares312
    Xencor Raises USD123 Million in Public Offering of Shares332
    Xencor Completes IPO For US$80.5 Million352
Xencor, Inc. - Key Competitors371
Key Employees381
Locations And Subsidiaries391
  Head Office391
  Other Locations &Subsidiaries391
Appendix401
  Methodology401
  About GlobalData401
  Contact Us401
  Disclaimer401

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Xencor, Inc. (XNCR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Xencor-Inc-XNCR-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6663>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Xencor, Inc. (XNCR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Xencor-Inc-XNCR-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6663>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research